Andrzej Tukiendorf
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 7
- Urology top 10%
-
- Inflammatory Biomarkers in Disease Prognosis 7
- Cutaneous Melanoma Detection and Management 6
-
- Bladder and Urothelial Cancer Treatments 14
- Urinary and Genital Oncology Studies 12
-
- Advanced Radiotherapy Techniques 10
-
- Prostate Cancer Treatment and Research 7
- Gastric Cancer Management and Outcomes 6
Andrzej Tukiendorf
108 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 113
- Internal Medicine 106
- Cardiology and Cardiovascular Medicine 224
- Urology 62
- Cancer Research 100
- Oncology 172
Countries citing papers authored by Andrzej Tukiendorf
This map shows the geographic impact of Andrzej Tukiendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Tukiendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Tukiendorf more than expected).
Fields of papers citing papers by Andrzej Tukiendorf
This network shows the impact of papers produced by Andrzej Tukiendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Tukiendorf. The network helps show where Andrzej Tukiendorf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrzej Tukiendorf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 9 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 0 | |
| 10 | 2021 | 15 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 30 | |
| 16 | [CyberKnife for prostate cancer patients. Update of 200 patients treatment results]. | 2018 | 1 |
| 17 | 2018 | 1 | |
| 18 | Calculation of planning target volume margins using the van Herk, Stroom and ICRU methods in patients with gastric cancer | 2018 | 0 |
| 19 | 2011 | 1 | |
| 20 | Prostate Cancer Incidence in Relation to Ethnic Situation in Opole Province, Poland | 2003 | 0 |
About Andrzej Tukiendorf
Andrzej Tukiendorf is a scholar working on Internal Medicine, Urology and Oncology, having authored 119 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (12 papers), Advanced Radiotherapy Techniques (10 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Inflammatory Biomarkers in Disease Prognosis (7 papers), Prostate Cancer Treatment and Research (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Internal Medicine (106 citations), Cardiology and Cardiovascular Medicine (224 citations) and Urology (62 citations). Andrzej Tukiendorf has collaborated with scholars based in Poland, Spain and Qatar. Frequent co-authors include Leszek Miszczyk, Phil McEwan, Andreas Clemens, Jerzy Wydmański, Christopher Ll. Morgan, Paul A. Robinson, Jonathan Plumb, Wojciech Krajewski, Romuald Zdrojowy and Grzegorz Mazur.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.